Oncotelic Therapeutics, Inc. (OTLC) income statement
OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.02+0.00 (+11.45%)
Close on Oct 19, 2026Market cap $8.66MP/E 0.0Yield –
Oncotelic Therapeutics, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- 184.0%
Financial strength
- Current ratio
- 0.08
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 1.0%
Valuation
- P/E ratio
- 0.0
- Price to sales
- –
- Price to book
- 0.03
- Dividend yield
- –
See a number that looks wrong?